Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06039033 · ClinicalTrials.gov registry record

Exploring Merkel Cell Carcinoma Clinical Trial Engagement Patterns

A clinical trial, sponsored by Power Life Sciences.

Not yet
Registry status
500
Enrollment target

NCT06039033 is a clinical trial that has not yet begun recruiting, run by Power Life Sciences. The registered enrollment target is 500 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06039033 has not yet begun recruiting, sponsored by Power Life Sciences.

NOT YET RECRUITING
Registry status
500 participants
Enrollment target

Study Summary

Taking part in medical research usually favors a particular demographic group. But there is limited research available to explain what trial attributes affect the completion of these specific demographic groups. This study will admit a wide range of data on the clinical trial experience of Merkel cell carcinoma patients to determine which factors prevail in limiting a patient's ability to join or finish a trial. It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future Merkel cell carcinoma patients.

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2024-10
Est. Completion 2026-10

Sponsor

Power Life Sciences

62 total trials

What the Registry Record Tells You About NCT06039033

The ClinicalTrials.gov registry entry for NCT06039033 describes a study currently listed as not yet recruiting, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Power Life Sciences, which has 62 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT06039033 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT06039033 about?

NCT06039033 is a clinical study titled "Exploring Merkel Cell Carcinoma Clinical Trial Engagement Patterns". Taking part in medical research usually favors a particular demographic group. But there is limited research available to explain what trial attributes affect the completion of these specific demographic groups. This study will admit a wide range of data on the clinical trial experience of Merkel c...

What is the current status of trial NCT06039033?

This trial is currently not yet recruiting. The enrollment target is 500 participants. The study started on 2024-10. Estimated completion is 2026-10.

Who is sponsoring clinical trial NCT06039033?

This trial is sponsored by Power Life Sciences, which has 62 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.